[HTML][HTML] HIV/SIV infection primes monocytes and dendritic cells for apoptosis

M Laforge, L Campillo-Gimenez, V Monceaux… - PLoS …, 2011 - journals.plos.org
M Laforge, L Campillo-Gimenez, V Monceaux, MC Cumont, B Hurtrel, J Corbeil, J Zaunders
PLoS pathogens, 2011journals.plos.org
Subversion or exacerbation of antigen-presenting cells (APC) death modulates
host/pathogen equilibrium. We demonstrated during in vitro differentiation of monocyte-
derived macrophages and monocyte-derived dendritic cells (DCs) that HIV sensitizes the
cells to undergo apoptosis in response to TRAIL and FasL, respectively. In addition, we
found that HIV-1 increased the levels of pro-apoptotic Bax and Bak molecules and
decreased the levels of anti-apoptotic Mcl-1 and FLIP proteins. To assess the relevance of …
Subversion or exacerbation of antigen-presenting cells (APC) death modulates host/pathogen equilibrium. We demonstrated during in vitro differentiation of monocyte-derived macrophages and monocyte-derived dendritic cells (DCs) that HIV sensitizes the cells to undergo apoptosis in response to TRAIL and FasL, respectively. In addition, we found that HIV-1 increased the levels of pro-apoptotic Bax and Bak molecules and decreased the levels of anti-apoptotic Mcl-1 and FLIP proteins. To assess the relevance of these observations in the context of an experimental model of HIV infection, we investigated the death of APC during pathogenic SIV-infection in rhesus macaques (RMs). We demonstrated increased apoptosis, during the acute phase, of both peripheral blood DCs and monocytes (CD14+) from SIV+RMs, associated with a dysregulation in the balance of pro- and anti-apoptotic molecules. Caspase-inhibitor and death receptors antagonists prevented apoptosis of APCs from SIV+RMs. Furthermore, increased levels of FasL in the sera of pathogenic SIV+RMs were detected, compared to non-pathogenic SIV infection of African green monkey. We suggest that inappropriate apoptosis of antigen-presenting cells may contribute to dysregulation of cellular immunity early in the process of HIV/SIV infection.
PLOS